Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Morgan Stanley Adjusts Resmed's Price Target to AU$31.80 From AU$28.60, Keeps at Overweight
Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target Is AU$31
Morgan Stanley Upgrades Resmed to Overweight From Equalweight, Adjusts Price Target to AU$26 From AU$27.70
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Teladoc (TDOC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) and Zur Rose Group AG (Six Swiss: CH:DOCM)
No Data